BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+26.74%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.78B
AUM Growth
+$1.78B
Cap. Flow
-$23.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
47.19%
Holding
82
New
6
Increased
3
Reduced
8
Closed
9

Top Buys

1
SWTX
SpringWorks Therapeutics
SWTX
$38.4M
2
VTYX icon
Ventyx Biosciences
VTYX
$29.7M
3
VERU icon
Veru
VERU
$28.8M
4
EXEL icon
Exelixis
EXEL
$19.6M
5
GOSS icon
Gossamer Bio
GOSS
$13.3M

Top Sells

1
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$42.9M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$37.1M
3
BPMC
Blueprint Medicines
BPMC
$15.3M
4
BMEA icon
Biomea Fusion
BMEA
$14.2M
5
MIST icon
Milestone Pharmaceuticals
MIST
$14.2M

Sector Composition

1 Healthcare 99.33%
2 Financials 0.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$140M 7.86% 2,000,000 – –
CYTK icon
2
Cytokinetics
CYTK
$4.23B
$102M 5.72% 2,100,000 – –
RXDX
3
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$101M 5.69% 1,714,000 – –
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
$97.6M 5.49% 3,421,541 +1,345,636 +65% +$38.4M
APLS icon
5
Apellis Pharmaceuticals
APLS
$3.48B
$89M 5.01% 1,303,700 – –
RVMD icon
6
Revolution Medicines
RVMD
$7.1B
$78.6M 4.42% 3,984,264 +500,000 +14% +$9.86M
ONC
7
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$67.4M 3.79% 500,000 – –
AMLX icon
8
Amylyx Pharmaceuticals
AMLX
$836M
$58.7M 3.3% 2,084,000 -116,000 -5% -$3.27M
TYRA icon
9
Tyra Biosciences
TYRA
$675M
$56.7M 3.19% 6,448,359 – –
RLAY icon
10
Relay Therapeutics
RLAY
$619M
$48.5M 2.73% 2,169,132 -500,000 -19% -$11.2M
SAGE
11
DELISTED
Sage Therapeutics
SAGE
$42.8M 2.41% 1,094,000 – –
GOSS icon
12
Gossamer Bio
GOSS
$562M
$42.8M 2.41% 3,571,928 +1,109,570 +45% +$13.3M
ITOS icon
13
iTeos Therapeutics
ITOS
$41M 2.31% 2,154,058 – –
MRUS icon
14
Merus
MRUS
$4.98B
$38.1M 2.14% 1,900,000 – –
PMVP icon
15
PMV Pharmaceuticals
PMVP
$74.2M
$37.6M 2.12% 3,163,795 -334,841 -10% -$3.98M
RCUS icon
16
Arcus Biosciences
RCUS
$1.13B
$37.5M 2.11% 1,432,200 – –
BLU
17
DELISTED
BELLUS Health Inc.
BLU
$33.8M 1.9% 3,200,000 – –
ANAB icon
18
AnaptysBio
ANAB
$569M
$33.2M 1.87% 1,300,000 – –
IDYA icon
19
IDEAYA Biosciences
IDYA
$2.15B
$32.9M 1.85% 2,202,812 – –
RETA
20
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$31.1M 1.75% 1,239,000 – –
VTYX icon
21
Ventyx Biosciences
VTYX
$171M
$29.7M 1.67% +850,000 New +$29.7M
VERU icon
22
Veru
VERU
$47.6M
$28.8M 1.62% +2,500,000 New +$28.8M
AKRO icon
23
Akero Therapeutics
AKRO
$3.74B
$28.3M 1.59% 831,495 – –
TNGX icon
24
Tango Therapeutics
TNGX
$747M
$24.9M 1.4% 6,871,642 – –
FOLD icon
25
Amicus Therapeutics
FOLD
$2.34B
$24.3M 1.37% 2,325,000 – –
1
2 3 4